14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:FPRX
Delisted

Five Prime Therapeutics Stock Price (Quote)

$38.00
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.00 $38.00 Friday, 27th May 2022 FPRX stock ended at $38.00. During the day the stock fluctuated 0% from a day low at $38.00 to a day high of $38.00.
90 days $38.00 $38.00
52 weeks $38.00 $38.00

Historical Five Prime Therapeutics prices

Date Open High Low Close Volume
Jan 04, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 03, 2022 $38.00 $38.00 $38.00 $38.00 0
Dec 31, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 30, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 29, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 28, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 27, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 23, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 22, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 21, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 20, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 17, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 16, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 15, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 14, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 13, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 10, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 09, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 08, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 07, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 06, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 03, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 02, 2021 $38.00 $38.00 $38.00 $38.00 0
Dec 01, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 30, 2021 $38.00 $38.00 $38.00 $38.00 0
Click to get the best stock tips daily for free!

About Five Prime Therapeutics

Five Prime Therapeutics Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with nivolumab; and is in Phase I/II... FPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT